New Approaches Improve Radiotherapy for Childhood Cancer

Radiotherapy is an important part of treatment for several types of childhood cancer, but it is not always effective enough when the disease has spread or returned. A new doctoral thesis from Karolinska Institutet explores several ways to make treatment more precise and effective, with the aim of helping more children survive cancer.

Children with high-risk neuroblastoma and rhabdomyosarcoma often need extensive treatment involving medicines, surgery and radiotherapy. Despite major advances, the outlook remains poor for some children, particularly when the cancer has spread or returned. At the same time, it is important to limit treatment-related damage to healthy parts of the body.

In her thesis, Se Whee Sammy Park at the Department of Oncology-Pathology studies a treatment in which a radioactive substance targets cancer cells in the body and delivers radiation directly to them. This approach could make it possible to reach tumours in several locations at once, which is particularly important when treating cancer that has spread.

Several routes to more effective treatments

However, results from an ongoing clinical study in children with neuroblastoma show that different tumours in the same patient can take up very different amounts of the radioactive substance. The researchers also found that tumours absorbed less radiation during the second treatment session. These findings led to changes in the study protocol, so that a larger proportion of the treatment is now given during the first session. The updated approach is already being used in the ongoing clinical study, with one patient treated under the new protocol so far.

Portrait photo of a woman with long black hair.
Se Whee Sammy Park. Photo: N/A

"Our findings show that there is no single solution. We need both to improve the delivery of radiation to the tumour and to find ways to make cancer cells more sensitive to treatment," says Se Whee Sammy Park.

The thesis also explores how cancer cells can be made more sensitive to radiation. After testing thousands of different substances, the researchers identified a promising way to weaken cancer cells' defences against cell death. In laboratory experiments, this enhanced the effects of radiation in both neuroblastoma and rhabdomyosarcoma. In experiments in mice, neuroblastoma tumours grew more slowly and the animals lived longer when two treatments were combined than when radiotherapy was used alone. The next step is to explore the possibility of taking the treatment forward into clinical studies.

The researchers also tested another type of radioactive treatment, which had a powerful effect on neuroblastoma cells in laboratory experiments and caused greater damage to the cancer cells' DNA. Together with recently published findings from experiments in mice carried out by collaborators on the project, these results suggest that other radioactive substances could also be promising options for treating childhood cancer.

Overall, the thesis identifies several possible routes towards more effective radiotherapy for childhood cancers that are difficult to treat, and suggests that several different strategies will probably need to be combined. The long-term goal is to cure more children and enable them to live long, healthy lives.

The dissertation takes place at 13:00 on 20 November 2026 in Eva & George Klein, Biomedicum, Solnavägen 9

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.